BI671800 in asthmatics receiving ICS

• Research type

  Research Study

• Full title

  Randomised, double-blind, double-dummy, placebo-controlled, parallel group study to assess the efficacy and safety of 6 weeks of oral BI 671800 ED 400 mg b.i.d., Montelukast 10 mg q.d. or placebo in symptomatic asthma patients on fluticasone propionate MDI

• IRAS ID

  34046

• Contact name

  Ian Hall

• Eudract number

  2009-014551-80

• ISRCTN Number

  N/A

• Research summary

  This is a 6 week study to assess the effect of BI 671800 in patients with asthma. It is a double blind, parallel arm trial testing the safety and efficacy of BI 671800. The main objective is to assess the effect on lung function. The study will also provide data on the pharmacokinetics of BI 671800.

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  10/H0803/30

• Date of REC Opinion

  21 Apr 2010

• REC opinion

  Further Information Favourable Opinion